Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Furer

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Internal Medicine Journal|April 12, 2021
Prevalence of COVID-19 and seroprevalence to SARS-CoV-2 in a rheumatologic patient population from a tertiary referral clinic in IsraelTali Eviatar, Ofir Elalouf, Victoria Furer, et al.
The Journal of Rheumatology|June 3, 2016
The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional StudyShay Brikman, Victoria Furer, Jonathan Wollman, et al.
The Journal of Rheumatology|October 15, 2022
Sex-Based Differences in Sonographic and Clinical Findings Among Patients With Psoriatic ArthritisVictoria Furer, Jonathan Wollman, David Levartovsky, et al.
Rheumatology International|October 25, 2019
Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional studyVictoria Furer, Shani Shenhar-Tsarfaty, Shlomo Berliner, et al.
Rheumatology (Oxford, England)|May 25, 2024
Ex vivo cell-based assay for assessment of response to TNF inhibitors in patients with rheumatic diseasesSmadar Gertel, May Rokach, Ari Polachek, et al.
Clinical and Experimental Rheumatology|September 8, 2021
Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseasesTali Eviatar, Victoria Furer, Ari Polachek, et al.
BMC Musculoskeletal Disorders|June 2, 2012
Malignancy validation in a United States registry of rheumatoid arthritis patientsMark C Fisher, Victoria Furer, Marc C Hochberg, et al.
Life (Basel, Switzerland)|March 29, 2023
Systemic Lupus Erythematous and Obstructive Sleep Apnea: A Possible AssociationRoni Meidan, Ofir Elalouf, Riva Tauman, et al.
Rheumatology (Oxford, England)|May 11, 2023
The association between sonographic enthesitis with sonographic synovitis and tenosynovitis in psoriatic arthritis patientsGavriel Balulu, Victoria Furer, Jonathan Wollman, et al.
Seminars in Arthritis and Rheumatism|September 10, 2013
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugsDaniel H Solomon, Joel M Kremer, Mark Fisher, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Internal Medicine Journal|April 12, 2021
Prevalence of COVID-19 and seroprevalence to SARS-CoV-2 in a rheumatologic patient population from a tertiary referral clinic in IsraelTali Eviatar, Ofir Elalouf, Victoria Furer, et al.
The Journal of Rheumatology|June 3, 2016
The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional StudyShay Brikman, Victoria Furer, Jonathan Wollman, et al.
The Journal of Rheumatology|October 15, 2022
Sex-Based Differences in Sonographic and Clinical Findings Among Patients With Psoriatic ArthritisVictoria Furer, Jonathan Wollman, David Levartovsky, et al.
Rheumatology International|October 25, 2019
Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional studyVictoria Furer, Shani Shenhar-Tsarfaty, Shlomo Berliner, et al.
Rheumatology (Oxford, England)|May 25, 2024
Ex vivo cell-based assay for assessment of response to TNF inhibitors in patients with rheumatic diseasesSmadar Gertel, May Rokach, Ari Polachek, et al.
Clinical and Experimental Rheumatology|September 8, 2021
Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseasesTali Eviatar, Victoria Furer, Ari Polachek, et al.
BMC Musculoskeletal Disorders|June 2, 2012
Malignancy validation in a United States registry of rheumatoid arthritis patientsMark C Fisher, Victoria Furer, Marc C Hochberg, et al.
Life (Basel, Switzerland)|March 29, 2023
Systemic Lupus Erythematous and Obstructive Sleep Apnea: A Possible AssociationRoni Meidan, Ofir Elalouf, Riva Tauman, et al.
Rheumatology (Oxford, England)|May 11, 2023
The association between sonographic enthesitis with sonographic synovitis and tenosynovitis in psoriatic arthritis patientsGavriel Balulu, Victoria Furer, Jonathan Wollman, et al.
Seminars in Arthritis and Rheumatism|September 10, 2013
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugsDaniel H Solomon, Joel M Kremer, Mark Fisher, et al.
Pageof 8